Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Rap1 signaling pathway	6/210	5.536037150501879e-08	4.617564303761976e-06	57.8235294117647	-190.69206916659132	FGF2;FGFR2;FGFR3;INS;MAPK3;PLCG1
KEGG_2021_Human	Ras signaling pathway	6/232	1.0038183269047773e-07	4.617564303761976e-06	52.04867256637168	-174.3857646205266	FGF2;FGFR2;FGFR3;INS;MAPK3;PLCG1
KEGG_2021_Human	Regulation of actin cytoskeleton	6/218	6.922665527616838e-08	4.617564303761976e-06	55.58490566037736	-184.4357455423547	FGF2;FGFR2;FGFR3;INS;MAPK3;PXN
KEGG_2021_Human	PI3K-Akt signaling pathway	6/354	1.2285229960677564e-06	4.23840433643376e-05	33.275862068965516	-116.99904255484728	FGF2;FGFR2;FGFR3;GH1;INS;MAPK3
KEGG_2021_Human	MAPK signaling pathway	5/294	1.3385871752255297e-05	0.0003694500603622462	26.91695501730104	-87.89458911862751	FGF2;FGFR2;FGFR3;INS;MAPK3
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	4/143	1.820556871612203e-05	0.0004187280804708067	38.02877697841727	-100.11084528203472	FGF2;FGFR2;FGFR3;MAPK3
KEGG_2021_Human	VEGF signaling pathway	3/59	4.2829644076396207e-05	0.0008443558403632395	61.316326530612244	-109.395777314067	MAPK3;PLCG1;PXN
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.0011504668914270244	51.17910447761194	-94.92366080084827	FGFR2;FGFR3;MAPK3
KEGG_2021_Human	Proteoglycans in cancer	4/205	7.503044944089289e-05	0.0011504668914270244	26.092868988391377	-71.58256188469439	FGF2;MAPK3;PLCG1;PXN
KEGG_2021_Human	Calcium signaling pathway	4/240	0.0001385943554693892	0.0019126021054775707	22.124293785310734	-61.303577347609085	FGF2;FGFR2;FGFR3;PLCG1
KEGG_2021_Human	Prostate cancer	3/97	0.00018948670381727933	0.0023771968297076865	36.35562310030395	-71.7056117119453	FGFR2;INS;MAPK3
KEGG_2021_Human	Pathways in cancer	5/531	0.00023006625856898829	0.0026457619735433652	14.338403041825096	-46.44758767649085	FGF2;FGFR2;FGFR3;MAPK3;PLCG1
KEGG_2021_Human	HIF-1 signaling pathway	3/109	0.00026769368967035696	0.0028416714749622506	32.19137466307278	-64.6303441766756	INS;MAPK3;PLCG1
KEGG_2021_Human	Leukocyte transendothelial migration	3/114	0.00030562208449801803	0.003012560547194749	30.72200772200772	-62.06423147737699	PLCG1;PXN;TXK
KEGG_2021_Human	Growth hormone synthesis, secretion and action	3/119	0.0003468783323520502	0.0031912806576388617	29.379310344827587	-59.68521503911596	GH1;MAPK3;PLCG1
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.004526844976430431	25.375266524520256	-52.38188378130509	MAPK3;PLCG1;PXN
KEGG_2021_Human	Phospholipase D signaling pathway	3/148	0.0006580280370873506	0.0051451694605702866	23.417733990147784	-48.687210890592894	INS;MAPK3;PLCG1
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.0051451694605702866	23.25440313111546	-48.37496566440217	FGF2;FGFR2;MAPK3
KEGG_2021_Human	cGMP-PKG signaling pathway	3/167	0.0009358557046094012	0.006457404361804868	20.65505226480836	-43.31808643668981	INS;MAPK3;NPPC
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	2/37	0.0008976760152685225	0.006457404361804868	57.378571428571426	-64.24352876962546	INS;MAPK3
KEGG_2021_Human	Bladder cancer	2/41	0.001102329014027565	0.007243876377895426	51.467948717948715	-59.107363137308084	FGFR3;MAPK3
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.008185498232543024	17.769924812030077	-37.496518500419114	FGF2;MAPK3;PLCG1
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.008185498232543024	45.59090909090909	-53.767249912981214	INS;MAPK3
KEGG_2021_Human	Chemokine signaling pathway	3/192	0.001402358175894933	0.008185498232543024	17.866213151927436	-37.69462705671507	MAPK3;PLCG1;PXN
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.010299991105545558	16.115516062884485	-34.04865723073064	MAPK3;PLCG1;PXN
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.015161247149456084	13.800705467372135	-29.076248648200146	MAPK3;PLCG1;PXN
KEGG_2021_Human	Fc epsilon RI signaling pathway	2/68	0.0030081604419031007	0.015375042258615848	30.310606060606062	-38.524679686703344	MAPK3;PLCG1
KEGG_2021_Human	Melanoma	2/72	0.003366354198306209	0.01548522931220856	28.564285714285713	-36.6281144505518	FGF2;MAPK3
KEGG_2021_Human	Non-small cell lung cancer	2/72	0.003366354198306209	0.01548522931220856	28.564285714285713	-36.6281144505518	MAPK3;PLCG1
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.01548522931220856	29.41176470588235	-37.553176952571945	INS;MAPK3
KEGG_2021_Human	Glioma	2/75	0.003647545225114028	0.016237459389217286	27.38013698630137	-35.32028634874201	MAPK3;PLCG1
KEGG_2021_Human	ErbB signaling pathway	2/85	0.004661598778005346	0.020103144730148056	24.051204819277107	-31.541623523071053	MAPK3;PLCG1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.021326816520302154	22.933908045977013	-30.23706529396038	MAPK3;PLCG1
KEGG_2021_Human	Th1 and Th2 cell differentiation	2/92	0.005440715912052039	0.021660698811581853	22.16111111111111	-29.32328202848766	MAPK3;PLCG1
KEGG_2021_Human	MicroRNAs in cancer	3/310	0.00549365549569105	0.021660698811581853	10.83434155421126	-22.425343286065555	FGFR3;MAPK3;PLCG1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.022645369069199214	20.331632653061224	-27.120602948412195	MAPK3;PLCG1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	2/100	0.006399778215208473	0.022645369069199214	20.331632653061224	-27.120602948412195	INS;MAPK3
KEGG_2021_Human	Choline metabolism in cancer	2/98	0.0061532112744065075	0.022645369069199214	20.760416666666668	-27.64199341159925	MAPK3;PLCG1
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	2/97	0.006031622120792857	0.022645369069199214	20.981578947368423	-27.909669646620806	MAPK3;PLCG1
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.02382707802717366	19.524509803921568	-26.130280011490946	MAPK3;PLCG1
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.02456430764867224	18.95952380952381	-25.42995427691617	MAPK3;PLCG1
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.02945319063013132	16.98931623931624	-22.939511285821055	MAPK3;PLCG1
KEGG_2021_Human	Thyroid hormone signaling pathway	2/121	0.009256905435456077	0.02970820814169625	16.699579831932773	-22.566638560549244	MAPK3;PLCG1
KEGG_2021_Human	Oocyte meiosis	2/129	0.010471317399144716	0.03235661908071515	15.631889763779528	-21.1770620526928	INS;MAPK3
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.03235661908071515	15.385658914728682	-20.853034219946885	MAPK3;PLCG1
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.03235661908071515	15.385658914728682	-20.853034219946885	INS;MAPK3
KEGG_2021_Human	Vascular smooth muscle contraction	2/133	0.011103972768351109	0.03260315408579687	15.146946564885496	-20.537590301958808	MAPK3;NPPC
KEGG_2021_Human	Insulin signaling pathway	2/137	0.011753397776716717	0.03310140598340627	14.690740740740742	-19.931093924152265	INS;MAPK3
KEGG_2021_Human	Autophagy	2/137	0.011753397776716717	0.03310140598340627	14.690740740740742	-19.931093924152265	INS;MAPK3
KEGG_2021_Human	Breast cancer	2/147	0.013449368234662449	0.03712025632766836	13.660344827586206	-18.543070369415922	FGF2;MAPK3
KEGG_2021_Human	mTOR signaling pathway	2/154	0.014697151111795944	0.039768761831918444	13.019736842105264	-17.666924126955095	INS;MAPK3
KEGG_2021_Human	Hepatocellular carcinoma	2/168	0.01733904421063664	0.04601515578976647	11.900602409638553	-16.11078229535683	MAPK3;PLCG1
KEGG_2021_Human	Axon guidance	2/182	0.020171001667084437	0.052520721321842496	10.955555555555556	-14.770188549056966	MAPK3;PLCG1
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.05534411301565865	10.536096256684491	-14.167050995225416	MAPK3;PLCG1
KEGG_2021_Human	Focal adhesion	2/201	0.02430775457262447	0.060990366018585034	9.885678391959798	-13.221635183162709	MAPK3;PXN
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.0610214648832874	9.784825870646767	-13.073912909097736	MAPK3;PXN
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.06673486205902882	9.219483568075118	-12.240131856521	MAPK3;PLCG1
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.07136817639820761	8.794843049327355	-11.607417281005194	MAPK3;PXN
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.07301958844238787	8.519565217391305	-11.194266119915625	MAPK3;PLCG1
KEGG_2021_Human	Maturity onset diabetes of the young	1/26	0.03174141642153645	0.07301958844238787	35.74666666666667	-18.6524135039421	INS
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.07587946412297486	8.26054852320675	-10.803362590978235	FGF2;MAPK3
KEGG_2021_Human	Endocytosis	2/252	0.036977605273484586	0.0823049923829173	7.818	-10.130623353400585	FGFR2;FGFR3
KEGG_2021_Human	Thyroid cancer	1/37	0.04489527895199197	0.09834203960912527	24.790123456790123	-13.876145105511855	MAPK3
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.11212957526902603	21.232804232804234	-12.171283962486152	INS
KEGG_2021_Human	Vibrio cholerae infection	1/50	0.060233261208856796	0.12647364782109755	18.183673469387756	-10.63265628196324	PLCG1
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.12647364782109755	5.880699088145897	-7.115618067766183	MAPK3;PXN
KEGG_2021_Human	Ovarian steroidogenesis	1/51	0.0614038724928517	0.12647364782109755	17.817777777777778	-10.44262436810124	INS
KEGG_2021_Human	Regulation of lipolysis in adipocytes	1/55	0.06607320562588742	0.13408974082900682	16.48971193415638	-9.74227359341278	INS
KEGG_2021_Human	Endometrial cancer	1/58	0.06956147443988561	0.13912294887977122	15.61598440545809	-9.271975415581295	MAPK3
KEGG_2021_Human	Long-term depression	1/60	0.07188046794101291	0.1417072082265683	15.08286252354049	-8.981081638876871	MAPK3
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.1428025659956785	5.2459128065395095	-6.1057863985118	INS;MAPK3
KEGG_2021_Human	GnRH secretion	1/64	0.07650285602324569	0.14663047404455423	14.11816578483245	-8.446736055993485	MAPK3
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.14910720759442303	13.47138047138047	-8.082458738692866	MAPK3
KEGG_2021_Human	Long-term potentiation	1/67	0.07995603885498047	0.14910720759442303	13.47138047138047	-8.082458738692866	MAPK3
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.15134312804996825	13.071895424836601	-7.854937277937848	MAPK3
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.15143247743554483	12.880837359098228	-7.74542097629872	PLCG1
KEGG_2021_Human	Adherens junction	1/71	0.08454220466511847	0.15151719797125127	12.695238095238095	-7.638591016595616	MAPK3
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.15193780425008874	11.68421052631579	-7.04872976578505	MAPK3
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.15193780425008874	11.841481481481482	-7.141387005986298	MAPK3
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.15193780425008874	11.841481481481482	-7.141387005986298	MAPK3
KEGG_2021_Human	Inositol phosphate metabolism	1/73	0.0868275630671275	0.15193780425008874	12.339506172839506	-7.43259286356604	PLCG1
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.15193780425008874	11.841481481481482	-7.141387005986298	MAPK3
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.15193780425008874	11.68421052631579	-7.04872976578505	PXN
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.15757914371303675	11.094444444444445	-6.698191160265787	MAPK3
KEGG_2021_Human	Insulin secretion	1/86	0.10155766145487406	0.16296461954386768	10.435294117647059	-6.300464747037211	INS
KEGG_2021_Human	Colorectal cancer	1/86	0.10155766145487406	0.16296461954386768	10.435294117647059	-6.300464747037211	MAPK3
KEGG_2021_Human	Gap junction	1/88	0.10380474953181053	0.1646558096021822	10.192848020434228	-6.152535327455873	MAPK3
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.1678082254963437	9.528076463560334	-5.7422174156532195	MAPK3
KEGG_2021_Human	Melanogenesis	1/101	0.11828795027183354	0.1678082254963437	8.853333333333333	-5.318405524022337	MAPK3
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.1678082254963437	9.130584192439862	-5.49346810373269	PLCG1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.1678082254963437	8.764576457645765	-5.262086311101535	INS
KEGG_2021_Human	IL-17 signaling pathway	1/94	0.11051569770952978	0.1678082254963437	9.528076463560334	-5.7422174156532195	MAPK3
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.1678082254963437	8.592233009708737	-5.152341092635986	PLCG1
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.1678082254963437	8.592233009708737	-5.152341092635986	MAPK3
KEGG_2021_Human	Circadian entrainment	1/97	0.11385418156418702	0.1678082254963437	9.226851851851851	-5.553951626329874	MAPK3
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.1678082254963437	4.014270613107822	-4.131104230952899	MAPK3;PLCG1
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.1678082254963437	8.764576457645765	-5.262086311101535	MAPK3
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.1678082254963437	8.592233009708737	-5.152341092635986	MAPK3
KEGG_2021_Human	Phosphatidylinositol signaling system	1/97	0.11385418156418702	0.1678082254963437	9.226851851851851	-5.553951626329874	PLCG1
KEGG_2021_Human	GnRH signaling pathway	1/93	0.1094003568916107	0.1678082254963437	9.632850241545894	-5.8073541800756905	MAPK3
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.16915531694084815	8.426455026455027	-5.046288872333345	MAPK3
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.17046927218965785	8.2668743509865	-4.943743954376122	INS
KEGG_2021_Human	Cholinergic synapse	1/113	0.1314697223892576	0.17096543468997313	7.892857142857143	-4.701617375992292	MAPK3
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.17096543468997313	7.964964964964965	-4.748494648054986	MAPK3
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.17096543468997313	7.964964964964965	-4.748494648054986	MAPK3
KEGG_2021_Human	Glutamatergic synapse	1/114	0.13256015588280526	0.17096543468997313	7.822025565388397	-4.655477238055189	MAPK3
KEGG_2021_Human	Serotonergic synapse	1/113	0.1314697223892576	0.17096543468997313	7.892857142857143	-4.701617375992292	MAPK3
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.1760790391083742	7.4858757062146895	-4.435243302362896	MAPK3
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.1760790391083742	7.4220354808590105	-4.393179099544486	INS
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.17989795313863643	7.177055103884372	-4.231046804704064	MAPK3
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.18228942547251945	7.00352733686067	-4.115510268264927	MAPK3
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.1833052467696475	6.892361111111111	-4.041189892105298	MAPK3
KEGG_2021_Human	Estrogen signaling pathway	1/137	0.15730251033809037	0.19041882830400414	6.480392156862745	-3.763669230249352	MAPK3
KEGG_2021_Human	Apelin signaling pathway	1/137	0.15730251033809037	0.19041882830400414	6.480392156862745	-3.763669230249352	MAPK3
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.191308444639419	6.384863123993559	-3.698840756963446	NPPC
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.19343374910256908	6.2466509062253746	-3.6047270952512624	MAPK3
KEGG_2021_Human	Retrograde endocannabinoid signaling	1/148	0.16890973234869874	0.19922686379590107	5.987150415721844	-3.427000500776257	MAPK3
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	1/150	0.1710046090025842	0.1999884410369205	5.905294556301268	-3.370661515310376	MAPK3
KEGG_2021_Human	Oxytocin signaling pathway	1/154	0.17518011116339122	0.20004312352575934	5.74800290486565	-3.2620286219941206	MAPK3
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.20004312352575934	5.70995670995671	-3.235678410841787	INS
KEGG_2021_Human	Cushing syndrome	1/155	0.17622102470306392	0.20004312352575934	5.70995670995671	-3.235678410841787	MAPK3
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.20004312352575934	5.672401433691756	-3.209640069203435	MAPK3
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.20004312352575934	5.635327635327635	-3.183908163692195	MAPK3
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.20255571423738145	5.456866804692892	-3.0596637281364782	MAPK3
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.20255571423738145	5.456866804692892	-3.0596637281364782	GH1
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.21218772394314642	5.131254061078622	-2.8313674486945275	MAPK3
KEGG_2021_Human	NOD-like receptor signaling pathway	1/181	0.20287322552436027	0.21872269626845092	4.869135802469136	-2.6461154603833723	MAPK3
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.21872269626845092	4.896958410924891	-2.6658400097237527	MAPK3
KEGG_2021_Human	Alcoholism	1/186	0.20790875456503763	0.22241401651143558	4.734534534534535	-2.5504914662503393	MAPK3
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.23235621011480195	4.462585034013605	-2.3563138595912863	MAPK3
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.23682921559426312	4.326732673267327	-2.2588473265567357	INS
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24832200051421816	4.058397932816537	-2.065502377074288	MAPK3
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.2494703093271264	4.001019367991845	-2.0240281738454993	MAPK3
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.27492605835676	3.503584229390681	-1.6629804039719844	PLCG1
KEGG_2021_Human	Salmonella infection	1/249	0.2689494049142217	0.27492605835676	3.503584229390681	-1.6629804039719844	MAPK3
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.29534623184484926	3.184640522875817	-1.4307154955453085	MAPK3
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3130769664386332	2.9380196523053668	-1.2513063817932166	GH1
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.3504975915199974	2.5254901960784313	-0.9533164047874388	GH1
